Latest
News

Here, we publish important new scientific research and materials, discuss significant NGP category developments in the media, report on scientific conferences we’ve attended, and more. Please note not all of this content is available in certain territories.

Blog Categories

Imperial Brands responds to the Tobacco Products Directive Evaluation Report

We respond to the recently published TPD Evaluation Report.

6 May 2026

Oral nicotine pouches in the US: Our Top 5 PATH Findings

Focusing on nicotine pouch use as reported in the latest wave of the ongoing PATH study, we explore the potential public health impact of this relatively new category in the US.

21 Apr 2026

World Nicotine Congress 2026 OpEd: The Industry Perspective – Real World Evidence

Real-world evidence is demonstrating tobacco harm reduction in action, so why do many public health bodies and regulators remain sceptical? Joe Thompson explains.

9 Apr 2026

Imperial Brands presents research at Society of Toxicology Annual Meeting

Our SOT science posters are showcasing our latest potential harm reduction data and comprehensive approach to product stewardship.

23 Mar 2026

Scientist QA:
What’s High
Content Screening?

Advancing Toxicology Manager Edgar Trelles Sticken explains how High Content Screening is helping our scientists to better understand NGP.

4 Mar 2026

vape ‘actual use’ behavioural studies – 7 key learnings

Here are more key findings from our blu actual use behavioural studies as our scientists dive more deeply into participants’ individual journeys…

10 Feb 2026

Showing 1 to 6 of 127 posts

Subscribe via Email